Cognito Therapeutics Joins Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias Project to Advance Next-Generation Clinical Measures

Jennifer E. Engen

CAMBRIDGE, Mass., May 09, 2022–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, today announced it has joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measures Development Project to support the advancement of its late-stage disease-modifying therapeutics pipeline for neurodegenerative diseases. […]